Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Within a decade since inception in 2007, Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.
Biophore is dedicated to consistently deliver complex & niche pharmaceutical products that exceed customer expectations and provide a rewarding work environment.
Biophores product range is diverse and balanced with NCE-1, Branded products and grandfather products.
Biophores portfolio is spread across 30 therapeutic segments and specialize in development and manufacturing of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.